Search Results - congwu+chi

2 Results Sort By:
Novel Heart Failure Therapy: Farnesyltransferase Inhibition Targets Protein Aggregation in Cardiomyocytes
Advantages First-in-Class Mechanism: Targets a novel pathway—protein farnesylation—for heart failure treatment. Broad Therapeutic Potential: Effective in both HFrEF and HFpEF, addressing a major unmet need. Tested in multiple preclinical models: Danon disease cardiomyopathy (genetic model); HFpEF (diet-induced and hypertensive models);...
Published: 10/14/2025   |   Inventor(s): Kunhua Song, Congwu Chi, Amanda Conniff
Keywords(s): Cardiovascular Diseases, Drug Repurpose, Medical Pharmaceuticals, Therapeutics
Category(s): Technology Classifications > Medical > Therapeutics, Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical > Biotechnology, Technology Classifications > Chemistry
A Novel Bioactive and Digradable Magnesium-based Screw Construct for Fracture Fixation
[Licensing negotiation in progress][Invitation for Expression of Interest- Deadline: 6 January 2019]We are inviting expressions of interest (EoI) for commercializing “A Novel Bioactive and Degradable Magnesium-based Screw Construct for Fracture Fixation” technology. The innovation is developed by Professor QIN Ling, of Orthopaedics and...
Published: 10/2/2022   |   Inventor(s): Ling QIN, Li Tian, To Ngai, Chi Wu, Kwok Sui Leung
Keywords(s):  
Category(s): Medical Devices